EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Identification of a Novel Homozygous SLC34A1 Missense Mutation and a Heterozygous SLC34A3 Deletion in an Infant with Nephrocalcinosis, Failure to Thrive, and Hypercalcemia

Glorián Mura-Escorche, Leire C García-Suarez, Isis Lebredo-Álvarez, Elena Ramos-Trujillo iD, Felix Claverie-Martin iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26178541 ↗

Kurz gefasst

Fallbericht in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Glorián Mura-Escorche und 4 weiteren Autor:innen. Beteiligte Einrichtung: Research Unit, Hospital Universitario Nuestra Señora de Candelaria, 38010 Santa Cruz de Tenerife, Spain. Hauptthemen laut MEDLINE: Nephrocalcinosis, Failure to Thrive, Hypercalcemia, Sodium-Phosphate Cotransporter Proteins, Type IIc. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Instituto de Salud Carlos III-Subdirección General de Evaluación y Fomento de la Investigación, European Regional Development Fund “Another way to build Europe”.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Renal phosphate transporters NaPi-IIa (SLC34A1) and NaPi-IIc (SLC34A3) play a crucial role in phosphate reabsorption in the proximal tubule. Biallelic loss-of-function variants in SLC34A1 and SLC34A3 cause two rare phosphate-wasting tubulopathies: idiopathic infantile hypercalcemia (IIH) and hereditary hypophosphatemic rickets with hypercalciuria, respectively. The phenotypes associated with these diseases are highly variable and sometimes overlap. Here, we report a rare case of a six-month-old girl of consanguineous parents with symptoms related to these diseases, including failure to thrive, nephrocalcinosis, hypercalcemia, hypophosphatemia with low TRP, elevated levels of 1,25-(OH)2D3, and suppressed PTH. An exome sequencing analysis was carried out to determine the genetic variants associated with her disease. Bioinformatics tools were used to assess variant pathogenicity. We identify a novel homozygous mutation in the SLC34A1 gene, c.1361C>T; p.(T454M), and a previously described heterozygous SLC34A3 101 bp deletion. Mutation p.(T454M) affects transmembrane domain 5 of the NaPi-IIa protein, which is involved in substrate binding, probably impairing phosphate transport. Our results suggest the diagnosis of IIH type 2 in our patient and highlight the importance of exome analysis in diagnosing these tubulopathies. We suggest that the coexistent heterozygous SLC34A3 deletion could increase the risk of renal calcifications and the severity of other symptoms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NephrocalcinosisFailure to ThriveHypercalcemiaSodium-Phosphate Cotransporter Proteins, Type IIcSodium-Phosphate Cotransporter Proteins, Type IIaHumansFemaleInfantMutation, MissenseHeterozygoteSequence DeletionConsanguinityHomozygote

Stichwörter der Autor:innen

SLC34A1SLC34A3bioinformatics predictionsexome analysisidiopathic infantile hypercalcemiamutationsphosphate cotransporters

Substanzen

SLC34A3 protein, humanSodium-Phosphate Cotransporter Proteins, Type IIcSLC34A1 protein, humanSodium-Phosphate Cotransporter Proteins, Type IIa

Autor:innen und Institutionen

  • Research Unit, Hospital Universitario Nuestra Señora de Candelaria, 38010 Santa Cruz de Tenerife, Spain.
  • Pediatrics Service, Hospital General de Fuerteventura, 35600 Puerto del Rosario, Spain.
  • Clinical Analysis Laboratory, Hospital General de Fuerteventura, 35600 Puerto del Rosario, Spain.
  • Nutrition and Bromatology Section, Department of Chemical Engineering and Pharmaceutical Technology, Universidad de La Laguna, 38200 San Cristóbal de La Laguna, Spain.

ORCID-Profile: Elena Ramos-Trujillo, Felix Claverie-Martin

Förderung

  • Instituto de Salud Carlos III
  • Instituto de Salud Carlos III-Subdirección General de Evaluación y Fomento de la Investigación
  • European Regional Development Fund “Another way to build Europe”
  • Fundación Canaria Instituto de Investigación Sanitaria de Canarias (FIISC)

Zitieren

APA

Mura-Escorche, G., García-Suarez, L. C., Lebredo-Álvarez, I., Ramos-Trujillo, E., & Claverie-Martin, F. (2025). Identification of a Novel Homozygous SLC34A1 Missense Mutation and a Heterozygous SLC34A3 Deletion in an Infant with Nephrocalcinosis, Failure to Thrive, and Hypercalcemia. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26178541

Vancouver

Mura-Escorche G, García-Suarez LC, Lebredo-Álvarez I, Ramos-Trujillo E, Claverie-Martin F. Identification of a Novel Homozygous SLC34A1 Missense Mutation and a Heterozygous SLC34A3 Deletion in an Infant with Nephrocalcinosis, Failure to Thrive, and Hypercalcemia. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26178541

BibTeX
@article{MuraEscorche2025,
  author = {Mura-Escorche, Glorián and García-Suarez, Leire C and Lebredo-Álvarez, Isis and Ramos-Trujillo, Elena and Claverie-Martin, Felix},
  title = {Identification of a Novel Homozygous SLC34A1 Missense Mutation and a Heterozygous SLC34A3 Deletion in an Infant with Nephrocalcinosis, Failure to Thrive, and Hypercalcemia},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26178541}
}
Kostenlos starten →